ClearPoint Neuro (CLPT) News
NASDAQ: CLPTHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CLPT news summary
We found 9 recent headlines mentioning ClearPoint Neuro (CLPT): 1 in the past week and 8 in the past 30 days, most often from Nasdaq, PR Newswire. CLPT is making an outsized move today, down 5.47% at $6.91, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "ClearPoint Neuro, Inc. Amends At-The-Market Equity Offering Sales Agreement to Increase Capacity to $150,000,000", was published by Nasdaq on Nov 19, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest ClearPoint Neuro headlines
- ClearPoint Neuro, Inc. Amends At-The-Market Equity Offering Sales Agreement to Increase Capacity to $150,000,000ClearPoint Neuro, Inc. entered into an amendment on November 18, 2026, to its At-The-Market Equity Offering Sales Agreement with Stifel, Nicolaus & Company, Incorporated. The amendment increases the…Nasdaq
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPTNEW YORK, Nov. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ClearPoint Neuro, Inc. ("ClearPoint" or the "Company") (NASDAQ: CLPT). Such investors are…PR Newswire
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPTNEW YORK, Nov. 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ClearPoint Neuro, Inc. ("ClearPoint" or the "Company") (NASDAQ: CLPT). Such investors are…PR Newswire
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPTNEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ClearPoint Neuro, Inc. ("ClearPoint" or the "Company") (NASDAQ: CLPT). Such investors are…PR Newswire
- ClearPoint Neuro (CLPT) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- ClearPoint Neuro, Inc. Q3 Loss Widens(RTTNews) - ClearPoint Neuro, Inc. (CLPT) announced Loss for its third quarter of -$7.46 millionNasdaq
- ClearPoint Neuro, Inc. Reports Third Quarter 2026 Revenue of $12.1 millionClearPoint Neuro, Inc. reported total revenue of $12.1 million for the third quarter ended September 30, 2026, representing a 36% increase from $8.9 million for the third quarter of 2025. The growth…Nasdaq
- Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings GrowthIdexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.NasdaqIDXX, CLPT
- ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?ClearPoint Neuro (CLPT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price…NasdaqCLPT, PEN